ZBE-24250-31219

4 vaccinations 9 coded responses 29 check-ins 8 free-text entries 3 call cases

Sex: Female
Age at first dose: 66+
ZIP prefix: 208 / MD
Registered: 2021-11-23

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-07
Dose 1 — Moderna
2021-04-08
Dose 2 — Moderna
2021-11-23
Registered in v-safe
2021-11-23
Dose 3 — Moderna
2021-11-23
Health check-in — day 0, dose 3
Feeling: Good · None

Adult check-in
2021-11-24
Survey response — days 1–6 daily, dose 3
MedDRA: No adverse event — Feeling: Good · Site: Pain

Free text: No

MedDRA releases: 2024-11 · check-in free text available
2021-11-25
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Redness, Swelling · None

Adult check-in
2021-11-26
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-11-27
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-11-28
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-11-29
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-11-30
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2021-12-07
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2021-12-14
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2021-12-21
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2021-12-30
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2022-01-05
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-02-22
Survey response — 3 months, dose 3
MedDRA: Pre-existing disease, Raynaud's phenomenon — Feeling: Good

Free text: Raynauds flare up in fingers and toes due to cold , typical for me in winter

MedDRA releases: 2024-11 · check-in free text available
2022-05-24
Dose 4 — Moderna
2022-05-24
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2022-05-24
Survey response — day 0, dose 4
MedDRA: Dizziness — Feeling: Good

Free text: 5-6 Short moments of "dizzy" sensation but they only spanned a 1-2hr period and very minor symptom

MedDRA releases: 2024-11 · check-in free text available
2022-05-26
Survey response — days 1–6 daily, dose 4
MedDRA: No adverse event — Feeling: Good

Free text: No

MedDRA releases: 2024-11 · check-in free text available
2022-05-27
Survey response — days 1–6 daily, dose 4
MedDRA: Dizziness, Vertigo — Feeling: Good

Free text: Periodic dizziness but I do get vertigo every 3-4 months and moments of dizzy feelings spread over frequent days.

MedDRA releases: 2024-11 · check-in free text available
2022-05-29
Survey response — days 1–6 daily, dose 4
MedDRA: No adverse event — Feeling: Good

Free text: No

MedDRA releases: 2024-11 · check-in free text available
2022-05-30
Health check-in — days 1–6 daily, dose 4
Feeling: Good · None

Adult check-in
2022-05-31
Health check-in — day 7, dose 4
Feeling: Good · None

Adult check-in
2022-06-07
Health check-in — day 14, dose 4
Feeling: Good

Adult check-in
2022-06-14
Health check-in — day 21, dose 4
Feeling: Good

Adult check-in
2022-06-22
Health check-in — day 28, dose 4
Feeling: Good

Adult check-in
2022-06-28
Health check-in — day 35, dose 4
Feeling: Good

Adult check-in
2022-07-05
Health check-in — day 42, dose 4
Feeling: Good

Adult check-in
2022-08-23
Survey response — 3 months, dose 4
MedDRA: Thyroid function test abnormal — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Thyroid levels changed and needed to increase levithroid dose

MedDRA releases: 2024-11 · check-in free text available
2022-08-23
Report sent to call center — 3 months, dose 4
Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-08-24
Call successful
Does not wish to fill out VAERS report
2022-11-29
Survey response — 6 months, dose 4
MedDRA: Hypothyroidism, Pain in extremity, Pelvic pain, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Symptoms: Hypothyroid fluctuation and leg and pelvic oain · Healthcare visit (other): Blood tests

MedDRA releases: 2024-11 · check-in free text available
2022-11-29
Report sent to call center — 6 months, dose 4
Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-11-30
Call 2 — Could Not Reach Participant
2022-12-05
Call 3 — Could Not Reach Participant
2023-05-24
Survey response — 12 months, dose 4
MedDRA: Injury — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

MedDRA releases: 2024-11
2023-05-24
Call case (no matching report) — Successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2023-05-25
Call 1 — Left Voicemail
2023-05-25
Call 1 — Left Voicemail
2023-05-25
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2023-05-25
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-07	Moderna	No
2	2021-04-08	Moderna	No
3	2021-11-23	Moderna	No
4	2022-05-24	Moderna	No

Call center

Reported	Outcome	VAERS-related outcome
2022-08-23	Successful 2022-08-24	Does not wish to fill out VAERS report
2022-11-29	Successful 2023-05-25	Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2023-05-24	Successful 2023-05-25	Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Free text

Release 10 — days 1–6 daily, dose 3

2021-11-24

Systemic reaction (other): No

Release 11 — 3 months, dose 3

2022-02-22

Symptoms: Raynauds flare up in fingers and toes due to cold , typical for me in winter

Release 11 — day 0, dose 4

2022-05-24

Systemic reaction (other): 5-6 Short moments of "dizzy" sensation but they only spanned a 1-2hr period and very minor symptom

Release 11 — days 1–6 daily, dose 4

2022-05-26

Systemic reaction (other): No

2022-05-27

Systemic reaction (other): Periodic dizziness but I do get vertigo every 3-4 months and moments of dizzy feelings spread over frequent days.

2022-05-29

Systemic reaction (other): No

Release 12 — 3 months, dose 4

2022-08-23

Symptoms: Thyroid levels changed and needed to increase levithroid dose

Release 12 — 6 months, dose 4

2022-11-29

Symptoms: Hypothyroid fluctuation and leg and pelvic oain

Healthcare visit (other): Blood tests

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Unevaluable event	·	·	✓
SD	Hypothyroidism	·	·	✓
SD	Injury	·	·	✓
SD	Pain in extremity	·	·	✓
SD	Pelvic pain	·	·	✓
SD	Pre-existing disease	·	·	✓
SD	Raynaud's phenomenon	·	·	✓
SD	Thyroid function test abnormal	·	·	✓
SRO	Dizziness	·	·	✓
SRO	No adverse event	·	·	✓
SRO	Vertigo	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release